Clinical trial
The Efficacy and Safety of Chinese Herbal Formula TJAOA103 for the Treatment of Genitourinary Syndrome of Menopause: A Prospective and Single-Arm Study
NCT07160127 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Chinese Herbal Formula TJAOA103 for the Treatment of Genitourinary Syndrome of Menopause: A Prospective and Single-Arm Study
- Lead sponsor
- Tongji Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 15, 2025
- Completion date
- September 15, 2027
- Enrollment
- 113 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
genitourinary syndrome of menopause (gsm)